Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Non-randomised, Prospective study to compare the efficacy of Ripasudil and Brimonidine in patients with Glaucoma or Ocular Hypertension

Trial Profile

A Non-randomised, Prospective study to compare the efficacy of Ripasudil and Brimonidine in patients with Glaucoma or Ocular Hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2018

At a glance

  • Drugs Brimonidine (Primary) ; Ripasudil (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2018 New trial record
    • 01 Jul 2018 Results published in the Graefes Archive for Clinical and Experimental Ophthalmology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top